These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6397028

  • 1. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
    Bonora E, Coscelli C, Butturini U.
    Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
    [Abstract] [Full Text] [Related]

  • 2. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [Abstract] [Full Text] [Related]

  • 3. Beta-cell function and metabolic control in insulin treated diabetics.
    Madsbad S, McNair P, Faber OK, Binder C, Christiansen C, Transbøl I.
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):196-200. PubMed ID: 6990673
    [Abstract] [Full Text] [Related]

  • 4. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Residual beta-cell function and metabolic stability in insulin-dependent diabetes mellitus.
    Nakamura H, Takagi A, Tsuda A, Momotsu T, Ito S, Shibata A.
    Tohoku J Exp Med; 1988 May; 155(1):71-80. PubMed ID: 3046059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Free fatty acids level may effect a residual insulin secretion in type 1 diabetes.
    Zmysłowska A, Wyka K, Szadkowska A, Mianowska B, Pietrzak I, Młynarski W.
    Pediatr Endocrinol Diabetes Metab; 2011 May; 17(1):26-9. PubMed ID: 21489353
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Duration of residual B-cell function in maturity-onset diabetes.
    Cignarelli M, Cospite MR, Stefanelli G, Guastamacchia E, Nardelli G, Giorgino R.
    Acta Diabetol Lat; 1984 May; 21(2):161-6. PubMed ID: 6382892
    [Abstract] [Full Text] [Related]

  • 18. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
    Sjöberg S, Ahrén B, Bolinder J.
    J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. beta-cell function in children with diabetes.
    Ludvigsson J, Heding LG.
    Diabetes; 1978 Oct; 27 Suppl 1():230-4. PubMed ID: 344114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.